COMMUNIQUÉS West-GlobeNewswire

Elevar Therapeutics Presents Results from Post-Hoc Analysis of CARES-310 Study Evaluating the Impact of Viral and Non-Viral Etiology on Survival in Hepatocellular Carcinoma
24/01/2025
Post-hoc analysis on survival outcomes for camrelizumab plus rivoceranib in patients with viral and non-viral hepatocellular carcinoma (HCC) demonstrated clinically meaningful overall survival and progression-free [...]
Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia
24/01/2025
GARDEN CITY, N.Y., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
24/01/2025
ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, [...]
Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners
24/01/2025
Niagara Falls, NY, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and [...]
Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
24/01/2025
Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and cognitive change, driving innovation in brain health Company highlights its [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
24/01/2025
THE WOODLANDS, TX, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how [...]
Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing
24/01/2025
VANCOUVER, British Columbia, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing [...]
SoftSmile and ClearCorrect Announce Settlement
24/01/2025
NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- SoftSmile, Inc., ClearCorrect Operating, LLC, and Institut Straumann AG announce that they have amicably settled all litigation and legal disputes between them. The companies [...]
475,000 members and counting: HOOPP adds 33 new employers in 2024
24/01/2025
HOOPP continues to expand retirement security to more Ontario healthcare workers TORONTO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- For 65 years, HOOPP has been committed to providing members with the lifetime pension they have [...]
Gelteq Appoints Matthew Jones as Head of Sports Performance
24/01/2025
Leading internationally-experienced sports nutritionist joins the Company’s growing team to expand its sports vertical NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company [...]
Sword Health Acquires Surgery Hero to Accelerate Global Growth and Expand its Presence in the UK
24/01/2025
As part of this acquisition, Sword Health will collaborate with 18 NHS trusts serving 10 million people to implement its AI Care model, enhancing care delivery and management while significantly reducing costs LONDON [...]
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
24/01/2025
Submission supported by positive results from global, Phase 3 4WHIM clinical trial; U.S. regulatory approval in WHIM syndrome granted in 2024 Decision on MAA expected in 1H 2026 BOSTON, Jan. 24, 2025 (GLOBE NEWSWIRE [...]
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
24/01/2025
Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025 ATH434-201 trial in early-stage MSA completed in November 2024 Positive interim [...]
Director/PDMR Shareholding
24/01/2025
DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support [...]
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
24/01/2025
SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution [...]
Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
24/01/2025
Bagsværd, Denmark, 24 January 2025 – Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly subcutaneous [...]
Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference
24/01/2025
WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]
Dermatology Group of Arkansas Welcomes a New Registered Nurse
24/01/2025
Shelby Brady joins Dermatology Group of Arkansas as an RN focused on skin health for patients in the Little Rock area LITTLE ROCK, Ark., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Dermatology Group of Arkansas is always seeking [...]
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
24/01/2025
ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial public offering of 7,325,000 American depositary shares (“ [...]

Pages